Peer-reviewed articles, experimental protocols, and in-depth analysis of genetic mechanisms
Discover how AC1MMYR2, a revolutionary small molecule inhibitor, targets miR-21 biogenesis to reverse epithelial-mesenchymal transition and suppress tumor growth in multiple cancer types.